Literature DB >> 18676184

Mechanism of intestinal lipoprotein overproduction in insulin resistant humans.

Hélène Duez1, Mirjana Pavlic, Gary F Lewis.   

Abstract

Triglyceride-rich lipoproteins (TRLs) derived from the intestine are increased in insulin resistant states both in the post-prandial and fasted state and are associated with increased cardiovascular risk. Impaired clearance has long been invoked to explain this accumulation of intestinal TRLs, but more recent studies have highlighted the fact that the production rate of apolipoprotein (apo) B-48-containing particles is also increased in insulin resistance and Type 2 diabetes. Recent data also indicate that the enterocyte, similar to the hepatocyte, overproduces lipoprotein particles in response to an elevation of plasma free fatty acids. It is not yet clear precisely how much this overproduction of intestinal lipoprotein particles contributes to the hypertriglyceridemia of insulin resistant states. We speculate that chronic intestinal overproduction of apoB-48 primes the intestine to rapidly and efficiently facilitate the absorption of ingested fat, enhancing the assembly and secretion of intestinal TRL, and hence contributing to post-prandial lipemia.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18676184     DOI: 10.1016/j.atherosclerosissup.2008.05.013

Source DB:  PubMed          Journal:  Atheroscler Suppl        ISSN: 1567-5688            Impact factor:   3.235


  14 in total

1.  Hoofbeats, zebras, and insights into insulin resistance.

Authors:  Robert A Hegele; Karen Reue
Journal:  J Clin Invest       Date:  2009-02       Impact factor: 14.808

Review 2.  The REV-ERBs and RORs: molecular links between circadian rhythms and lipid homeostasis.

Authors:  Laura A Solt; Douglas J Kojetin; Thomas P Burris
Journal:  Future Med Chem       Date:  2011-04       Impact factor: 3.808

3.  Synthesis of specific fatty acids contributes to VLDL-triacylglycerol composition in humans with and without type 2 diabetes.

Authors:  M S Wilke; M A French; Y K Goh; E A Ryan; P J Jones; M T Clandinin
Journal:  Diabetologia       Date:  2009-06-18       Impact factor: 10.122

4.  APOB-516 T allele homozygous subjects are unresponsive to dietary changes in a three-month primary intervention study targeted to reduce fat intake.

Authors:  Ahd Hammoud; Marguerite Gastaldi; Matthieu Maillot; Charles S Mercier; Catherine Defoort; Denis Lairon; Richard Planells
Journal:  Genes Nutr       Date:  2009-10-20       Impact factor: 5.523

5.  Short Term Palmitate Supply Impairs Intestinal Insulin Signaling via Ceramide Production.

Authors:  Thi Thu Trang Tran; Bárbara Graziela Postal; Sylvie Demignot; Agnès Ribeiro; Céline Osinski; Jean-Paul Pais de Barros; Agnieszka Blachnio-Zabielska; Armelle Leturque; Monique Rousset; Pascal Ferré; Eric Hajduch; Véronique Carrière
Journal:  J Biol Chem       Date:  2016-06-02       Impact factor: 5.157

6.  Quercetin represses apolipoprotein B expression by inhibiting the transcriptional activity of C/EBPβ.

Authors:  Makoto Shimizu; Juan Li; Jun Inoue; Ryuichiro Sato
Journal:  PLoS One       Date:  2015-04-15       Impact factor: 3.240

7.  Characterization of the proteome of cytoplasmic lipid droplets in mouse enterocytes after a dietary fat challenge.

Authors:  Theresa D'Aquila; Devika Sirohi; Jeffrey M Grabowski; Victoria E Hedrick; Lake N Paul; Andrew S Greenberg; Richard J Kuhn; Kimberly K Buhman
Journal:  PLoS One       Date:  2015-05-18       Impact factor: 3.240

8.  Arterial retention of remnant lipoproteins ex vivo is increased in insulin resistance because of increased arterial biglycan and production of cholesterol-rich atherogenic particles that can be improved by ezetimibe in the JCR:LA-cp rat.

Authors:  Rabban Mangat; Samantha Warnakula; Faye Borthwick; Zahra Hassanali; Richard R E Uwiera; James C Russell; Christopher I Cheeseman; Donna F Vine; Spencer D Proctor
Journal:  J Am Heart Assoc       Date:  2012-10-25       Impact factor: 5.501

9.  Proteomic analysis of lipid droplets from Caco-2/TC7 enterocytes identifies novel modulators of lipid secretion.

Authors:  Frauke Beilstein; Julien Bouchoux; Monique Rousset; Sylvie Demignot
Journal:  PLoS One       Date:  2013-01-02       Impact factor: 3.240

10.  Novel insights into the regulation of postprandial lipemia by glucagon-like peptides: significance for diabetes.

Authors:  Gerald F Watts; Dick C Chan
Journal:  Diabetes       Date:  2013-02       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.